Advancements in metabolic drug therapies and public health updates define today's major medical developments.

Clinical trial results for retatrutide demonstrate significant weight loss and A1c reductions in patients with Type 2 diabetes alongside potential cardiovascular benefits.

A new IARC report highlights that nearly 1 in 8 cancers worldwide are linked to infections, emphasizing the critical role of vaccinations and early disease screening.

Data from the SURPASS-CVOT study suggests that tirzepatide may provide additional health benefits, including reduced infection-related mortality and improved patient-reported outcomes.

The FDA has launched a national recruitment campaign seeking scientists, medical experts, and consumer advocates to join its specialized advisory panels.

The US Senate Committee on Health, Education, Labor and Pensions has officially advanced the nomination of Dr. Nicole Saphier for the position of US Surgeon General.

A study indicates that the combination of L-arginine and liposomal vitamin C significantly reduces fatigue levels in patients undergoing pulmonary rehabilitation for advanced COPD.

Research reveals that children with epidermal differentiation disorders experience varying growth impairments, with SPINK5 variants linked to persistent height deficits.

New findings suggest that while CT urography and cytology could decrease the reliance on ureteroscopies for monitoring urothelial cancer, they currently risk missing a high number of tumor recurrences.